➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Moodys
Merck
Dow
AstraZeneca

Last Updated: September 25, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR


Email this page to a colleague

« Back to Dashboard

SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Gilead Sciences Inc VOSEVI sofosbuvir; velpatasvir; voxilaprevir TABLET;ORAL 209195 NDA Gilead Sciences, Inc. 61958-2401-1 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-2401-1) 2017-07-18
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Medtronic
Harvard Business School
Mallinckrodt
Boehringer Ingelheim